NCT06798246View on ClinicalTrials.gov

HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 1, 2027

Study Completion Date

January 1, 2030

Conditions

Upper Tract Urothelial Carcinoma

Interventions

DRUG

Chemotherapy

Gemicitabin and cisplatin

DRUG

Immunotherapy

PD-1/PD-L1

DRUG

ADC

ADC drug like RC48

DRUG

Chemotherapy combined with immunotherapy

All Listed Sponsors

collaborator

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER

collaborator

Peking University Third Hospital

OTHER

collaborator

Fujian Provincial Hospital

OTHER

lead

Peking University First Hospital

OTHER

NCT06798246 - HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study | Biotech Hunter | Biotech Hunter